In a digital world, people are increasingly concerned about data privacy. The pharmaceutical industry is no exception. The growing importance of data privacy requires companies to prioritize effective patient consent and preference management. Personalized medicine, electronic health records, and an evolving regulatory landscape make it more difficult to manage sensitive data, which is rapidly growing in volume. If robust systems are not implemented, inconsistencies and errors resulting from these challenges can lead to regulatory risks and a loss of patient trust. Solutions such as master data management (MDM), combat these difficulties by offering a centralized platform for data, which fosters an enhanced and streamlined approach. In addition, robust data governance policies are essential for managing the availability, security, and compliance of patient data.
This proactive management of data will help patients feel protected and confident in the use of their data which produces more active participants in research, studies, and feedback. The advancement of personalized medicine and digital technologies necessitates the prioritization of these practices to drive innovation, ensure regulatory compliance, and satisfy the evolving needs of patients.
At Greenlight, we understand that data privacy and protection are top of mind for patients at any stage of their healthcare journey. We are uniquely equipped to connect data and trust by enabling patients to have transparency and authority over their health information sharing. Through the safeguarding of data, we can foster trust and encourage greater communication between patients and providers.
Read the full article here: Why data practices are key for pharma firms to engage patients – Health Data Management
